ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NWPHF Newron Pharmaceuticals SPA (GM)

9.36
0.00 (0.00%)
27 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 56.59M73.02M59.73M60.29M51.2M50.49M37.2M25.87M
Total Current Assets 56.14M72.8M59.51M59.95M37.87M39.43M28.49M19.65M
Cash and Equivalents 42.95M56.29M27.62M20.27M13.21M25.02M13.42M6.34M
Total Non-Current Assets 49.75M67.72M54.84M36.8M17.25M3.11M-14.03M-29.91M
Total Liabilities 6.84M5.3M4.89M23.49M33.95M47.38M51.23M55.77M
Total Current Liabilities 6.65M4.73M4.28M5.6M6.89M3.65M5.04M28.93M
Total Non-Current Liabilities 199k576k606k34.64M52.73M86.27M91.35M52.6M
Total Equity 49.75M67.72M54.84M36.8M17.25M3.11M-14.03M-29.91M
Common Equity 3.16M3.57M3.57M3.57M3.57M3.57M3.57M3.57M
Retained Earnings -19.78M-10.46M-20.2M-25.34M-26.16M-20.12M-22.81M-21.4M

Your Recent History